Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer

被引:332
作者
Briganti, Alberto
Chun, Felix K. -H.
Salonia, Andrea
Suardi, Nazareno
Gallina, Andrea
Da Pozzo, Luigi Filippo
Roscigno, Marco
Zanni, Giuseppe
Valiquette, Luc
Rigatti, Patrizio
Montorsi, Francesco
Karakiewicz, Pierre I.
机构
[1] Univ Montreal, Ctr Hlth, Canc Prognost & Hlth Outcomes Unit, Montreal, PQ H2X 3J4, Canada
[2] Vita Salute Univ, Dept Urol, Milan, Italy
关键词
prostate cancer; radical prostatectomy; pelvic lymphadenectomy; complications;
D O I
10.1016/j.eururo.2006.08.015
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives: More-extensive pelvic lymph node dissection (PLND) may be associated with a higher rate of complications and a longer hospital stay than more limited PLND. Methods: Before radical retropubic prostatectomy, PLNDs were performed in 963 patients. Of these, 767 (79.6%) had >= 10 lymph nodes removed and examined (extended PLND [ePLND]), while 1-9 nodes (limited PLND [lPLND]) were removed in the remaining 196 (20.4%). Limits included external iliac, obturator, internal iliac, and iliac bifurcation. PLND-related complications and the length of hospital stay were recorded prospectively and analyzed according to the extent of PLND. Results: In patients subjected to ePLND, the overall rate of complications was 19.8% versus 8.2% in those treated with lPLND (p < 0.001). In individual analyses of specific complications, only the lymphocele rate was significantly higher after ePLND (10.3% vs 4.6%; p=0.01). Similarly, ePLND translated into a longer hospital stay (9.9 vs 8.2 d; p < 0.001). These differences persisted when adjustment was made for prostate-specific antigen and either clinical or pathologic tumor characteristics. Conclusions: Our data indicate that, even in the hands of experienced urologic surgeons, ePLNDs are associated with higher complication rates and longer hospital stay. These detriments need to be taken into account when the staging benefit associated with ePLND is considered. (c) 2006 European Association of Urology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1006 / 1013
页数:8
相关论文
共 24 条
[1]   Anatomical extent of lymph node dissection: Impact on men with clinically localized prostate cancer [J].
Allaf, ME ;
Palapattu, GS ;
Trock, BJ ;
Carter, HB ;
Walsh, PC .
JOURNAL OF UROLOGY, 2004, 172 (05) :1840-1844
[2]   Intraoperative and perioperative morbidity of contemporary radical retropubic prostatectomy in a consecutive series of 1243 patients: Results of a single center between 1999 and 2002 [J].
Augustin, H ;
Hammerer, P ;
Graefen, M ;
Palisaar, R ;
Noldus, J ;
Fernandez, S ;
Huland, H .
EUROPEAN UROLOGY, 2003, 43 (02) :113-118
[3]   EAU guidelines on prostate cancer [J].
Aus, G ;
Abbou, CC ;
Bolla, M ;
Heidenreich, A ;
Schmid, HP ;
van Poppel, H ;
Wolff, J ;
Zattoni, F .
EUROPEAN UROLOGY, 2005, 48 (04) :546-551
[4]   Is a limited lymph node dissection an adequate staging procedure for prostate cancer? [J].
Bader, P ;
Burkhard, FC ;
Markwalder, R ;
Studer, UE .
JOURNAL OF UROLOGY, 2002, 168 (02) :514-518
[5]   Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? [J].
Bader, P ;
Burkhard, FC ;
Markwalder, R ;
Studer, UE .
JOURNAL OF UROLOGY, 2003, 169 (03) :849-854
[6]   Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. [J].
Bergqvist, D ;
Agnelli, G ;
Cohen, AT ;
Eldor, A ;
Nilsson, PE ;
Le Moigne-Amrani, A ;
Dietrich-Neto, F .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (13) :975-980
[7]   Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph node's retrieved in cystectomy specimens [J].
Bochner, BH ;
Herr, HW ;
Reuter, VE .
JOURNAL OF UROLOGY, 2001, 166 (06) :2295-2296
[8]  
Cheng L, 2001, CANCER-AM CANCER SOC, V91, P66, DOI 10.1002/1097-0142(20010101)91:1<66::AID-CNCR9>3.0.CO
[9]  
2-P
[10]   Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer [J].
Clark, T ;
Parekh, DJ ;
Cookson, MS ;
Chang, SS ;
Smith, ER ;
Wells, N ;
Smith, JA .
JOURNAL OF UROLOGY, 2003, 169 (01) :145-147